PSYG — Psyence Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$2.80m
- CA$2.63m
2019 December 31st | 2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 10 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.019 | -0.093 | -11.3 | -4.6 | -6.08 |
Depreciation | |||||
Non-Cash Items | 0 | -0.03 | 9.17 | 0.955 | 0.406 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.013 | 0.076 | -0.117 | 0.033 | 1.94 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.032 | -0.046 | -2.2 | -3.56 | -3.64 |
Capital Expenditures | — | — | -0.376 | -0.164 | -0.264 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.004 | -0.147 | -0.166 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -0.373 | -0.311 | -0.43 |
Financing Cash Flow Items | — | 0.03 | — | — | -0.034 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | — | 0.03 | 8.67 | 1.27 | 2.96 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.032 | -0.016 | 6.1 | -2.6 | -1.11 |